Pricing Log in Create free account

Cypherpunk Technologies Inc. (CYPH) vs Relmada Therapeutics, Inc. (RLMD)

Cypherpunk Technologies Inc. and Relmada Therapeutics, Inc. are both Biotechnology companies. Cypherpunk Technologies Inc. and Relmada Therapeutics, Inc. are of similar size ($341.3M and $325.5M). Relmada Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Cypherpunk Technologies Inc. trades at 4.4×. Across the 9 metrics below, Cypherpunk Technologies Inc. leads on 7 and Relmada Therapeutics, Inc. on 2.

Valuation

Metric CYPH RLMD Biotechnology median
P/E 4.36 n/m 8.50
P/S 315.82 n/m 9.71
P/B 3.40 1.69 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 310.73 n/m 9.21
Earnings yield 22.96% (29.03%) (33.15%)
Free cash flow yield (4.44%) (36.56%) (25.50%)

Profitability

Metric CYPH RLMD Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (1.21%) (55.66%) (56.36%)
Return on assets (1.08%) (51.57%) (48.04%)
Return on invested capital (8.44%) 0.00% 0.00%

Growth

Metric CYPH RLMD Biotechnology median
Revenue growth (TTM) 0.00% — 6.02%
EPS growth (last fiscal year) 103.87% 45.28% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CYPH RLMD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 79.19 29.52 4.72
Net debt to EBITDA 0.34 1.57 0.96

Dividend

Metric CYPH RLMD Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CYPH RLMD Biotechnology median
Market cap 325.45m 341.34m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack